OP Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
AIM
AAMU
ECSS
OP Asset Management's BIIB Position: Q2 2026 in Review
OP Asset Management increased its Biogen (BIIB) stake by 9.8% in Q2 2026, buying an estimated $286K and bringing the position to 16,758 shares worth $3.62M. The position accounts for 0.04% of the portfolio, ranked #324.
OP Asset Management first reported a position in BIIB in Q1 2025 and has held it in 6 quarters since. 413 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- OP Asset Management held 16,758 shares of Biogen worth $3.62M as of Q2 2026.
- OP Asset Management bought 1,495 Biogen shares in Q2 2026, an estimated $286K.
- Biogen made up 0.04% of OP Asset Management's portfolio in Q2 2026, its #324 holding.
- OP Asset Management first reported a position in Biogen in Q1 2025 and has held it in 6 quarters since.
- 413 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.